Melissa Campbell

12.6k citations
45 papers · 6.1k · 5 hit papers · h-index 24

Impact in

    • SARS-CoV-2 and COVID-19 Research
    • COVID-19 Clinical Research Studies
    • SARS-CoV-2 detection and testing
  • Neurology top 1%
    • Long-Term Effects of COVID-19

Papers in

    • SARS-CoV-2 and COVID-19 Research 12
    • COVID-19 Clinical Research Studies 10
    • SARS-CoV-2 detection and testing 5
    • Long-Term Effects of COVID-19 4
    • Neurological disorders and treatments 3

Melissa Campbell

43 papers receiving 6.0k citations

Melissa Campbell's Hit Papers

Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination 2022 · 285 citations
2850+2+4Years since publication50010001.5k

Peers

Melissa Campbell
Comparison fields: 5 of 155
  • Infectious Diseases 3.6k
  • Neurology 1.3k
  • General Dentistry 131
  • Modeling and Simulation 201
  • Immunology 699
Replace Tianyang Mao with:
Tianyang Mao United States
Lorenzo R. Sewanan United States
Shelli Farhadian United States
Jon Klein United States
Alice Lu-Culligan United States
Eriko Kudo Japan
Júlio Dos Santos Silva United States
Michael H. Askenase United States
William Khoury-Hanold United States
Sofia E. Velazquez United States
Melissa Campbell relative to Tianyang Mao United States Tianyang Mao's profile →
Citations per field
00.5×2×2.6×
Tianyang Mao · 1×
Citations per year

Countries citing papers authored by Melissa Campbell

Since Specialization
Citations

This map shows the geographic impact of Melissa Campbell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melissa Campbell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melissa Campbell more than expected).

Fields of papers citing papers by Melissa Campbell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melissa Campbell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melissa Campbell. The network helps show where Melissa Campbell may publish in the future.

Co-authors

The 25 scholars most cited alongside Melissa Campbell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Melissa Campbell Line = papers co-authored together Melissa Campbell links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Longitudinal analyses reveal immunological misfiring in severe COVID-19
Hit paper breakdown →
20201572
2
Sex differences in immune responses that underlie COVID-19 disease outcomes
Hit paper breakdown →
20201010
3
Diverse functional autoantibodies in patients with COVID-19
Hit paper breakdown →
2021728
4
Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2
Hit paper breakdown →
2020683
5
Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination
Hit paper breakdown →
2022285
6 2017238
7 2020209
8 2021172
9 2021165
10 2020148
11 2022146
12 2019119
13
Tardive and withdrawal dyskinesia in autistic children: a prospective study.
198896
14 202359
15 202151
16 202248
17 202145
18 202136
19 202335
20
Neuropsychiatry and White Matter Microstructure in Huntington's Disease.
201531

About Melissa Campbell

Melissa Campbell is a scholar working on Infectious Diseases, Neurology, Cellular and Molecular Neuroscience, Psychiatry and Mental health and Radiology, Nuclear Medicine and Imaging, having authored 45 papers that have together received 6.1k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (10 papers), SARS-CoV-2 detection and testing (5 papers), Genetic Neurodegenerative Diseases (5 papers), Long-Term Effects of COVID-19 (4 papers), Attention Deficit Hyperactivity Disorder (3 papers), Mitochondrial Function and Pathology (3 papers) and Neurological disorders and treatments (3 papers). The work is most often cited by research in Infectious Diseases (3.6k citations), Neurology (1.3k citations), General Dentistry (131 citations), Modeling and Simulation (201 citations) and Immunology (699 citations). Melissa Campbell has collaborated with scholars based in United States, United Kingdom and Australia. Frequent co-authors include Phillip Adams, Jorge L. Armenteros, Richard A. Perry, Albert Icksang Ko, Akiko Iwasaki, Rupak Datta, Mark A. Yarhouse, Eric Y. Wang, Shelli Farhadian and Yile Dai. Their work appears in journals such as Nature, Open Forum Infectious Diseases, Emerging infectious diseases, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact